000 | 01933 a2200541 4500 | ||
---|---|---|---|
005 | 20250518033840.0 | ||
264 | 0 | _c20200922 | |
008 | 202009s 0 0 eng d | ||
022 | _a1445-2197 | ||
024 | 7 |
_a10.1111/ans.15122 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNadi, Sinan | |
245 | 0 | 0 |
_aSafety and effectiveness of aspirin and enoxaparin for venous thromboembolism prophylaxis after total hip and knee arthroplasty: a systematic review. _h[electronic resource] |
260 |
_bANZ journal of surgery _c10 2019 |
||
300 |
_a1204-1210 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Systematic Review | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aArthroplasty, Replacement, Hip _xadverse effects |
650 | 0 | 4 |
_aArthroplasty, Replacement, Knee _xadverse effects |
650 | 0 | 4 |
_aAspirin _xtherapeutic use |
650 | 0 | 4 |
_aAustralia _xepidemiology |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 |
_aDrug Therapy, Combination _xmethods |
650 | 0 | 4 |
_aEnoxaparin _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNetwork Meta-Analysis |
650 | 0 | 4 |
_aOrthopedics _xorganization & administration |
650 | 0 | 4 |
_aPlacebos _xadministration & dosage |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aSafety |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVenous Thromboembolism _xetiology |
700 | 1 | _aVreugdenburg, Thomas D | |
700 | 1 | _aAtukorale, Yasoba | |
700 | 1 | _aMa, Ning | |
700 | 1 | _aMaddern, Guy | |
700 | 1 | _aRovers, Maroeska | |
773 | 0 |
_tANZ journal of surgery _gvol. 89 _gno. 10 _gp. 1204-1210 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/ans.15122 _zAvailable from publisher's website |
999 |
_c29593358 _d29593358 |